Stay updated on Nivolumab for IDH Mutant Gliomas Clinical Trial

Sign up to get notified when there's something new on the Nivolumab for IDH Mutant Gliomas Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab for IDH Mutant Gliomas Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page now includes posted results (Results First Posted/Submitted) and a new PDF for the Study Protocol and SAP; enrollment and completion dates are updated and the study status is now Completed.
    Difference
    2%
    Check dated 2025-11-10T01:59:50.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The page shows only minor textual edits and formatting adjustments in the Study Details section, with core content such as eligibility criteria, outcomes, and intervention unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-03T00:46:16.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Added: Results Submitted. Removed: No Results Posted.
    Difference
    0.1%
    Check dated 2025-10-12T11:53:06.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    - Added a prominent notice about potential outages due to lapse in government funding and updated operating status guidance. - Updated version from v3.1.0 to v3.2.0.
    Difference
    3%
    Check dated 2025-10-05T07:28:16.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    Upgrade noted: version from v3.0.2 to v3.1.0. No other content changes detected.
    Difference
    0.1%
    Check dated 2025-09-28T02:57:09.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    Updated revision from v3.0.1 to v3.0.2; removed Back to Top element.
    Difference
    0.2%
    Check dated 2025-09-13T17:17:27.000Z thumbnail image

Stay in the know with updates to Nivolumab for IDH Mutant Gliomas Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab for IDH Mutant Gliomas Clinical Trial page.